Related Experiment Video

Updated: May 18, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

HPV 6, 11, 16, 18 vaccine in men. Inadequate assessment

    Prescrire International
    |September 29, 2012
    PubMed

    Insights

    Human papillomavirus (HPV) vaccination for young men aged 16-26 reduced genital warts. However, the vaccine’s ability to prevent cancer requires further investigation.

    Area of Science:

    • Oncology
    • Vaccinology
    • Public Health

    Background:

    • Genital warts are a common sexually transmitted infection caused by specific HPV types.
    • Cervical cancer and other anogenital cancers are strongly linked to persistent HPV infection.

    Purpose of the Study:

    • To evaluate the efficacy of quadrivalent HPV vaccine in preventing anogenital warts in young men.
    • To assess the potential of HPV vaccination in reducing the incidence of HPV-related cancers in males.

    Main Methods:

    • A randomized controlled trial involving 4065 males aged 16 to 26 years.
    • Participants received the quadrivalent HPV (6, 11, 16, 18) vaccine or a placebo.
    • Follow-up assessments monitored for the development of anogenital warts and other HPV-related conditions.

    Main Results:

    • The HPV vaccine significantly reduced the incidence of anogenital warts in the vaccinated group compared to the placebo group.
    • No data was collected or analyzed regarding the prevention of HPV-related cancers within the study period.

    Conclusions:

    • Quadrivalent HPV vaccination is effective in preventing anogenital warts among young men.
    • The long-term protective effect of this vaccine against HPV-associated cancers in males warrants further long-term studies.

    More Related Videos

    RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma10:26

    RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

    Published on: March 11, 2014

    Related Concept Videos

    Cancer Vaccines01:30

    Cancer Vaccines

    Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
    Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
    Disorders of the Male Reproductive System01:20

    Disorders of the Male Reproductive System

    Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
    Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
    Infertility in Males01:23

    Infertility in Males

    Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
    Mitral Valve Prolapse II: Assessment and Management01:22

    Mitral Valve Prolapse II: Assessment and Management

    IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
    Vaccines01:21

    Vaccines

    Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
    Nursing Assessment of the Genitourinary System I: Health History01:21

    Nursing Assessment of the Genitourinary System I: Health History

    The genitourinary system is critical to maintaining fluid balance, waste elimination, and reproductive function. Nurses play a vital role in assessing this system, beginning with a thorough health history. This process involves gathering patient information, identifying risk factors, and recognizing symptoms of genitourinary disorders. Early detection is vital for timely interventions and management.1. Gathering Patient InformationA complete health history includes the patient’s personal,...